Daniel Oliver is the CEO and co-founder of Rejuvenate Bio, a George Church lab spinout that is developing gene therapies to reverse aging in dogs.

Our second monthly Future of Longevity panel discussion featuring:

• George Church (Harvard Medical School)
• Nir Barzilai (Albert Einstein College of Medicine)
• Kristen Fortney (BioAge Labs)
• Jim Mellon (Juvenescence)
• Jay Olshansky (University of Illinois at Chicago)
• Alejandro Ocampo (University of Lausanne)

Anil Bhushan is a professor at the University of California San Francisco and also a co-founder of Deciduous Therapeutics, a longevity biotech company developing an immunotherapy to remove senescent cells.

A panel talk with scientists and thought leaders in age reversal and longevity science. Featuring:

• Aubrey de Grey (Founder of SENS Research Foundation, author of "Ending Aging")
• David Sinclair (Harvard Medical School, Life Biosciences, author of "Lifespan: Why We Age -- and Why We Don't Have to")
• Joao Pedro de Magalhaes (University of Liverpool, CSO at Centaura)
• Liz Parrish (Founder of Bioviva Science)
• Jean Hebert (Albert Einstein College of Medicine, author of "Replacing Aging")
• Alexandra Stolzing (SENS Research Foundation, Loughborough University)
• Greg Fahy (Intervene Immune)
• David Gobel (Methuselah Foundation, Methuselah Fund)

Hosted by: Laura Minquini (MYKIGAI, Let's Talk Longevity), Avi Roy (Oxford University), and Nathan Cheng (Longevity Marketcap / Longevity List)

Sebastian Brunemeier is a geroscientist, biotech founder, and venture capitalist. He was formerly Principal at Apollo Health Ventures, one of the largest aging-focussed VC firms in the world. Sebastian was co-founder of Samsara Therapeutics, Cyclone Therapeutics, Cambrian Biopharma, and advisor to several other biotech startups and Healthspan Capital.

Marinna Madrid is a co-founder of Cellino, a startup that leverages AI, robotics, and laser-editing to develop and manufacture stem cell therapies at scale. She obtained her Ph.D in Physics from Harvard and was named a Forbes Top 30 under 30 in healthcare.

Tyler Golato is one of the masterminds behind VitaDAO, a decentralized organization that aims to fund and commercialize longevity research -- all on the Ethereum blockchain.

Marco Quarta is a co-founder and CEO of Rubedo Life Science, a company developing targeted therapies to extend healthspan. Rubedo has built a drug discovery platform with an initial focus on prodrugs that remove senescent cells in a highly selective manner.